I

Inotiv

Global CRO for life sciences research

Facilities Maintenance Technician 2

Full-TimeDeadline 10/14/26
$26 - $29/hr
Junior
Associate's
Fort Collins, CO, USA
In Person
General Maintenance & RepairBuilding & Property Maintenance

About the job

Requirements
  • High school diploma or equivalent.
  • Two years of experience in a maintenance or service role that includes HVAC, electrical, plumbing, and general contract work; an equivalent number of years of education, craft apprenticeship, or production maintenance experience may be substituted.
  • Familiarity with relevant safety regulations and procedures.
  • Proficiency in using hand tools, power tools, and diagnostic equipment.
  • A valid state-issued driver's license with a current address and an acceptable driving record is required.
  • Ability to regularly lift up to 50 pounds and move heavy equipment safely.
  • Ability to stand and move throughout an entire work shift, including prolonged standing for up to eight or more hours per day.
  • Manual dexterity to operate necessary equipment and perform essential tasks.
  • Close visual acuity and depth perception, with or without glasses or contacts.
  • Use of provided personal protective equipment is required.
  • Regular on-site attendance as scheduled by management is required.
  • Occasional evening and weekend hours are required to meet service demands.
  • Ability to use hand and power tools, including power drills and drivers, reciprocating saws, power sanders and grinders, and other common construction and maintenance tools.
  • Ability to use ladders, boom lifts, scissor lifts, fork trucks, and other powered maintenance equipment.
  • Knowledge of light bulbs, including fluorescent, incandescent, LED, and halogen types.
  • Knowledge of HVAC, plumbing, and electrical materials, including PVC, galvanized metal, insulated and non-insulated electrical wire, PVC cement, drywall joint compound, and necessary solvents and chemicals.
  • Knowledge of generators, air compressors, water filtration systems, and hazardous waste equipment.
  • Ability to comply with applicable safety, laboratory, and company policies and procedures, including good documentation practices and applicable regulatory requirements.
  • Ability to maintain confidential information and complete assigned training requirements with appropriate documentation.
Responsibilities
  • Take ownership of and resolve maintenance requests by troubleshooting, diagnosing, ordering replacement parts, and repairing mechanical and electrical issues; record and track work in the Computer-Aided Facilities Management system.
  • Complete preventative maintenance as directed.
  • Repair and adjust equipment and facility infrastructure, including doors, locks, windows, and flooring.
  • Perform light plumbing, painting, electrical, and carpentry functions.
  • Routinely check heating and air conditioning equipment to ensure it is functioning properly.
  • Maintain accurate records of maintenance activities, including work orders, repairs, and inspections.
  • Assist facility personnel with office moves and workstation setups, and help set up and tear down events and special meetings.
  • Perform routine facility inspections to ensure compliance with safety and other regulatory requirements.
  • Operate company vehicles between buildings to move supplies, as needed.
  • Read and interpret equipment manuals and work orders to perform required maintenance and service.
  • Comply with safety regulations and maintain a neat, clean, and orderly work area.
  • Participate in rotational on-call availability for after-hours maintenance and facility security.
  • Use hand and power tools, electric meters, and material handling equipment to perform duties.
  • Monitor and ensure that the environment maintains proper temperature and humidity ranges under United States Department of Agriculture regulations.
  • Coordinate third-party service repairs as needed.
  • Become familiar with the equipment program to support equipment owners in scheduling service and maintaining documentation for compliance.
  • Follow standard operating procedures and other applicable laboratory or company policies and procedures.
  • Participate in company initiatives as directed.
  • Periodically review applicable standard operating procedures for accuracy and confirm procedures are being followed; participate in writing, reviewing, and revising procedures as needed.
  • Maintain compliance with applicable requirements, including Good Laboratory Practices, United States Department of Agriculture, Association for Assessment and Accreditation of Laboratory Animal Care, and Office of Laboratory Animal Welfare regulations.
  • Perform other duties as assigned.
Desired Qualifications
  • An associate degree in mechanical, electrical, or industrial maintenance, or a related field.
  • Technical certification in HVAC, plumbing, or electrical systems.

About the company

Inotiv provides contract research services across drug discovery, preclinical testing, analytical testing, and related areas for the pharmaceutical and biotech industries. Its offerings combine analytical chemistry, preclinical research, and access to a broad set of research models to generate data and prepare regulatory-compliant documentation that supports drug development, safety testing, and medical device evaluation. The company differentiates itself through an integrated CRO model that pairs BASi’s analytical capabilities, Seventh Wave’s preclinical work, and Envigo’s research models in one end-to-end service. Its goal is to be a global partner for drug discovery, safety assessment, and product development by delivering scalable research services and regulatory-grade data to biopharma and medical device customers.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

West Lafayette, Indiana

Founded

1974

Get referred to Inotiv

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 20, 2026 restructuring improved liquidity and strengthened Inotiv's balance sheet.
  • Q1 fiscal 2026 backlog reached $145.4 million, supporting near-term DSA revenue visibility.
  • Management kept normal operations through bankruptcy, preserving clients, vendors, and service continuity.

What critics are saying

  • June 2026 Chapter 11 cancelled existing equity, wiping out prior shareholders.
  • USDA cited Inotiv facilities in April 2026 and August 2026 for critical violations.
  • Animal-welfare scandals and bankruptcy stigma threaten customer trust and future contract wins.

What makes Inotiv unique

  • Inotiv pairs preclinical CRO services with research models and analytical capabilities.
  • July 2026 emergence from Chapter 11 cut about $326 million of debt.
  • Its VUGENE collaboration adds AI bioinformatics across Discovery and Translational Sciences.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Pension
  • Life Insurance
  • Wellbeing Program
  • Paid Time Off
  • 401(k) Retirement Plan
  • Flexible Work Hours
  • Remote Work Options
  • Stock Options
  • Company Equity
  • Conference Attendance Budget
  • Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

20%

1 year growth

20%

2 year growth

20%
Pryor Cashman
Jun 22nd, 2026
Pryor Cashman represents Acquiom Agency Services as DIP Agent and administrative and collateral in Inotiv Chapter 11 cases.

Pryor Cashman represents Acquiom Agency Services as DIP Agent and administrative and collateral in Inotiv Chapter 11 cases. Pryor Cashman has been engaged as counsel to Acquiom Agency Services LLC ("Acquiom"), in its roles as (i) DIP Agent for the Debtor-in-Possession Loan Credit Agreement, and (ii) administrative and collateral agent under the Prepetition First Lien Credit Agreement in the Chapter 11 bankruptcy cases of Inotiv, Inc. ("Inotiv") and its affiliated debtors. Inotiv is a contract research organization that provides drug discovery and development services to the pharmaceutical and medical device industries. On June 3, 2026, Inotiv and certain of its affiliates filed for bankruptcy protection in the United States Bankruptcy Court for the Southern District of Texas. The Pryor Cashman team representing Acquiom includes Partner Seth H. Lieberman, Chair of the Bankruptcy, Reorganization, and Creditors' Rights Group and Co-Chair of the Corporate Trust Practice; Partner Patrick Sibley, Co-Chair of the Corporate Trust Practice; Partner David W. Smith; Counsels Arsala Kidwai and Andrew S. Richmond; and Associate Daniel Brenner.seth Related people. Related services & industries. Firm Highlights Slide 1 of 10

Inotiv
Jun 3rd, 2026
Inotiv Reaches Agreement to Strengthen Capital Structure and Position Company for Future Growth

Receives commitments for $65 million in new money financing to support ongoing business operations Recapitalization effectuated through a pre-packaged plan of reorganization on an expedited basis Transaction is supported by substantially all of the Company’s existing lenders Normal business operations will continue seamlessly with no impact on vendors and suppliers Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it has entered into a Restructuring Support Agreement (“RSA”) with its Prepetition First Lien Lenders and Ad Hoc Group of Noteholders, constituting substantially all of its junior creditors, to implement a comprehensive recapitalization transaction that will strengthen its capital structure. To implement the transaction, Inotiv has filed a voluntary, prepackaged chapter

StockTitan
Dec 11th, 2025
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Inotiv partners with VUGENE to advance ai-driven drug Discovery and bioinformatics capabilities. Rhea-AI summary. Inotiv (NASDAQ: NOTV) announced a strategic collaboration with VUGENE on December 11, 2025 to integrate VUGENE's cloud-based AI/ML multi-omics bioinformatics platform into Inotiv's Discovery & Translational Sciences Division. The partnership aims to accelerate AI-assisted drug discovery by improving interpretation of epigenomic, proteomic, and other molecular datasets to better predict drug efficacy and safety in early-stage research. Inotiv said the integration will enable more efficient, data-driven decision making for client discovery programs, while VUGENE expects broader application of its computational technologies in real-world research settings. News market reaction 1 alert. On the day this news was published, NOTV declined 4.48%, reflecting a moderate negative market reaction. Data tracked by StockTitan Argus on the day of publication. Technical Shares at 0.8414 are trading below the 200-day MA of 1.87 and 87.02% under the 52-week high. Peers on Argus 1 down. Sector peers show mixed moves, with ADVB down 9.61% and others modestly up or down. With only one peer in momentum and no shared news, the AI-focused partnership appears company-specific rather than part of a sector-wide move. Historical context. | Date | Event | Sentiment | Move | Catalyst | | Dec 03 | Earnings report | Positive | +8.1% | Reported FY2025 revenue growth and sharply reduced operating loss. | | Nov 25 | Growth ranking | Positive | +3.9% | Ranked 182nd on Deloitte Technology Fast 500 with 448% growth. | | Nov 21 | Earnings date notice | Neutral | -3.9% | Announced timing and access details for FY2025 results call. | | Nov 17 | Preliminary results | Positive | -33.2% | Shared preliminary FY2025 revenue and strong DSA growth metrics. | | Oct 21 | Conference participation | Neutral | -2.2% | Outlined participation in multiple November investor conferences. | Operationally positive news has sometimes aligned with gains but also seen sharp selloffs, indicating inconsistent market confidence in updates. Over the last few months, Inotiv reported improving FY2025 results with Q4 revenue of $138.1M and FY revenue of $513.0M, alongside a narrowed operating loss of $30.9M. Recognition on the 2025 Deloitte Technology Fast 500(TM) and strong DSA growth, with backlog around $138M, highlight expansion. However, preliminary results on Nov 17, 2025 coincided with a -33.2% move, contrasting with the later earnings-day gain of 8.13%. Today's AI partnership adds to a pattern of strategic initiatives amid volatile reactions. Regulatory & risk context. An effective S-3 shelf filed on 2025-08-29 allows future securities offerings, including an at-the-market equity program with up to 3.0% commission. The filing highlights an auditor's explanatory paragraph raising substantial doubt about going-concern status, material weaknesses in internal control, and warns of immediate dilution risk and variable ATM proceeds. Market pulse summary. This announcement details a strategic collaboration integrating VUGENE's AI-enabled bioinformatics platform into Inotiv's Discovery & Translational Sciences Division to better analyze complex epigenomic and proteomic data. It follows FY2025 revenue of $513.0M and recognition in the 2025 Deloitte Technology Fast 500(TM). Regulatory filings, including the 2025-08-29 S-3, highlight going-concern language, internal-control weaknesses, and dilution risk. Investors may watch how this AI partnership translates into Discovery and Safety Assessment growth and backlog trends.

StockTitan
Dec 23rd, 2024
Inotiv Raises $24M in Equity Offering

Inotiv completed an equity offering, raising approximately $24 million by selling 6 million common shares at $4.25 each. The offering closed on December 19, 2024, with Lake Street Capital Markets as the sole book-running manager. An option allows underwriters to purchase up to 900,000 additional shares until January 17, 2025. The funds will be used for working capital, capital expenditures, and general corporate purposes to enhance financial flexibility and support strategic initiatives.

GlobeNewswire
Dec 18th, 2024
Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares

WEST LAFAYETTE, Ind., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...